• Facebook
  • X
  • Instagram
  • RSS
  • Advertise
  • TradeIQ Concert
  • Research Reports
  • Heatmap
  • Billionaires
  • Entrepreneurs
  • Entertainment
  • Banking
  • Gold & Metals
  • Real Estate
  • Crypto Press Release
0 Items
Trade Brains
  • Indian Markets
    • Editors Pick
    • Bulk/Block Deals
    • Corporate Action
    • Large-cap
    • Mid-cap
    • Micro-Penny
    • Recent Orders
    • Results
    • IPO Analysis
    • FPO Analysis
    • Stock Ideas
    • Technical
  • Global Markets
    • US Markets
    • Trump News
    • Asian Markets
    • European Markets
  • Digital Assets
    • Crypto
    • NFT
  • Business
    • Billionaires
    • Entrepreneurs
    • Fintech
    • Innovation
    • Leadership
    • Startups
  • Money
    • Gold & Metals
    • Banking
    • Credit Card
    • Mutual Funds
    • ETFs
    • Hedge Funds
    • Insurances
    • Real Estate
    • Retirement
    • Personal Finance
  • Lifestyle
  • Sports
Select Page
Pharma stock in focus after successfully raising ₹4,500 Cr via QIP; Do you hold it?

Pharma stock in focus after successfully raising ₹4,500 Cr via QIP; Do you hold it?

by Trade Brains | June 20, 2025 12:41 pm | Indian Markets, Mid-cap, News, Stocks

During Friday’s trading session, shares of a global biopharmaceutical company manufacturing biotechnology products and research services are in focus on the stock exchanges, after successfully raising Rs. 4,500 crores via a Qualified Institutions Placement (QIP). With...
Pharma stock in focus after successfully raising ₹4,500 Cr via QIP; Do you hold it?

Pharma stock jumps after receiving approval to raise ₹4,500 Cr via QIP

by Trade Brains | June 17, 2025 11:18 am | Indian Markets, Mid-cap, News, Stocks

During Tuesday’s trading session, shares of a global biopharmaceutical company engaged in the manufacturing of biotechnology products and research services are in focus, after the company launched a Qualified Institutions Placement (QIP) to raise up to Rs. 4,500...
Pharma stock jumps after receiving approval for its diabetes drug

Pharma stock jumps after receiving approval for its diabetes drug

by Trade Brains | June 3, 2025 11:47 am | Indian Markets, Mid-cap, News, Stocks

Shares of a leading pharmaceutical company rose nearly 2 percent in today’s trading session after the firm announced it had secured regulatory approval for its new diabetes drug. The development marks a significant milestone in the company’s efforts to expand its...
Pharma stock jumps 3% after receiving USFDA approval for cancer treatment drugs

Pharma stock jumps 3% after receiving USFDA approval for cancer treatment drugs

by Trade Brains | March 5, 2025 2:14 pm | News, Stocks

Pharma stock that offers generic formulations and API products, including anti-diabetics, immunosuppressants, and many more in focus after receiving US FDA’s approval for Key Cancer drugs. Price Movement With a market capitalization of ₹38,251 Crores the shares of...
Pharma stock jumps 3% after receiving USFDA approval for cancer treatment drugs

Pharma stock in focus after receiving European Commission approval for its new medicine

by Trade Brains | February 18, 2025 2:50 pm | News, Stocks

This leading pharma company stock is in focus after its drug, YESINTEK has been approved by the European Commission for marketing in the European Union region. Share Price Movement With a market capitalization of Rs. 40,322 Crore, the stock of Biocon opened at Rs....
Pharma stock jumps 3% after receiving USFDA approval for cancer treatment drugs

Pharma stock jumps after receiving approval from China’s NMPA for Tacrolimus capsules

by Trade Brains | January 3, 2025 11:36 am | News, Stocks

One of the pharmaceutical stocks engaged in the manufacturing of biotechnology products and research services. The stock is in focus after receiving approval from China’s National Medical Products Administration (NMPA) for Tacrolimus capsules  Stock Price...
Candlesticks and chart trading mastery

Search Topic or Keyword

Easiest Stock Screener Tool!

Best stock discovery tool with +130 filters, built for fundamental analysis. Profitability, Growth, Valuation, Liquidity, and many more filters. Search Stocks Industry-wise, Export Data For Offline Analysis, Customizable Filters.

  • — Stock Screener
  • — Compare Stocks
  • — Stock Buckets
  • — Portfolio Backtesting

Start your stock analysis journey with Trade Brains Portal today. Launch here!

Keep the Learning On!

Subscribe to Youtube to watch our latest stock market videos. Subscribe here.

About Trade Brains

Trade Brains is India’s trusted financial and business news portal.

Phone: 080884 91790

Email: [email protected]

Quick Links

  • Trade Brains Portal
  • Stock Screener
  • Compare Stocks
  • Trade Brains News
  • Candlesticks Books
  • Fingrad
  • Subscribe on Youtube

Contact and Partnership

Reach us out at

  • Phone: [+91] 8088491790
  • Email: [email protected]

For Advertisement, Press Releases, Partnerships or to get backlinks on this website, please e-mail us at [email protected]

For Partnerships & Promotio

Visit  – tradebrainsawards.com/

Chandan Singh Rawat
Emaill: [email protected]
Mob: (+91)6366648573

Bikram Singhary
Email: [email protected]
Mob: (+91)8088491790

Other Links

  • Upcoming Dividend Stocks
  • Upcoming Bonus Issue
  • Nifty 50 Heatmap
  • Stock Research Reports
  • Trending Stocks Today
  • Stock Comapre
  • Newsslash

 

 

  • About
  • Careers
  • Advertise & Backlinks
  • Terms and Conditions
  • Disclaimer & Privacy Policy
  • Contact
  • Submit Press Release
  • Facebook
  • X
  • Instagram
  • RSS
2025 © Tradebrains Technologies Pvt Ltd - All Right Reserved